Anticipated retatrutide side effects The initial clinical trials reported various side effects associated with retatrutide, with higher doses generally resulting in more noticeable symptoms
Its not yet approved for regular clinical use and is still being investigated, with Phase 3 trials currently underway
Further Reading For additional peer-reviewed research, see: retatrutide dosing schedule overview
Takes ~5 minutes HIPAA-secure intake Cancel anytime Compounded GLP-1 therapy activates GLP-1 receptors to regulate blood sugar and increase fullness, reducing food intake and supporting effective weight loss
Are video visits with a doctor required
GLP-1 is an endocrine hormone secreted by enteroendocrine L-cells located in the distal jejunum, ileum and colon that express the glucagon gene and produce proglucagon (Lee et al., 1990)